In a recent USDA-funded study led by CVM’s Dr. Kimberly VanderWaal and Dr. Dennis Makau, researchers developed a model to predict the likely difference in pig immune response to new strains of PRRS—information that can help guide immunization protocols and drive new vaccine development for more effective disease management.